Category: Hematology

Abstract 177 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Celgene

177 – CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma Abstract Presentation Abstract View author list and disclosures Author(s): Deepu Madduri, MD1*, Jesus G. Berdeja, MD2, Saad Z. Usmani, MD, MBBS, MBA3, Andrzej Jakubowiak, MD, PhD4, Mounzer Agha, MD5, Adam D. Cohen,…

Read the full article

A collection of abstracts from the 62nd ASH® Annual Meeting & Exposition, courtesy of Celgene

141 – Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial Abstract Presentation Abstract View author list and disclosures Author(s): Francesca Gay, MD, Pellegrino Musto, Delia Rota Scalabrini*, Monica Galli*, Angelo Belotti, MD*, Elena Zamagni, MD*, Luca Bertamini, MD*, Renato Zambello*, Micol Quaresima*, Giovanni De Sabbata*, Giuseppe Pietrantuono*, Mattia D’Agostino,…

Read the full article

An abstract from the 62nd ASH® Annual Meeting & Exposition, courtesy of Gilead

1187 – Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel) Abstract Presentation Slides Abstract View author list and disclosures Author(s): Caron Jacobson, MD, MMSc1, Frederick L. Locke, MD2, Armin Ghobadi, MD3, David B. Miklos, MD, PhD4, Lazaros J. Lekakis, MD5*, Olalekan O.…

Read the full article

A collection of abstracts from the 62nd ASH® Annual Meeting & Exposition, courtesy of Jazz Pharmaceuticals (MSL)

2375 – Analysis of Risk Factors for Hepatic Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients Abstract Presentation Abstract View author list and disclosures Author(s): Bernd Gruhn*, Grit Brodt, MD*, Jana Ernst, MD* and Jaspar Kloehn* Department of Pediatrics, Jena University Hospital, Jena, Germany*signifies non-member of ASH Disclosures: No relevant conflicts…

Read the full article

Abstract 143 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Celgene

143 – Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial Abstract Presentation Abstract View author list and disclosures Author(s): Aurore Perrot, MD, PhD, Valerie Lauwers-Cances, Titouan Cazaubiel, Thierry Facon, MD, Denis Caillot, Lauriane Clement-Filliatre, Margaret Macro, Olivier Decaux, Karim Belhadj, MD, Mohamad Mohty,…

Read the full article

A collection of abstracts from the 62nd ASH® Annual Meeting & Exposition, courtesy of Jazz Pharmaceuticals (KAM)

2375 – Analysis of Risk Factors for Hepatic Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients Abstract Presentation Abstract View author list and disclosures Author(s): Bernd Gruhn*, Grit Brodt, MD*, Jana Ernst, MD* and Jaspar Kloehn* Department of Pediatrics, Jena University Hospital, Jena, Germany*signifies non-member of ASH Disclosures: No relevant conflicts…

Read the full article

Abstract 1369 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Celgene

1369 – Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Patients with Multiple Myeloma Treated with Continuous Lenalidomide Maintenance Therapy: A Clinical and Correlative Phase 2 Study Abstract Presentation Abstract View author list and disclosures Author(s): Benjamin Diamond, MD, Neha Korde, MD, Alexander M. Lesokhin, MD, Eric L Smith, MD, PhD, Urvi A Shah, MD,…

Read the full article

Abstract 984 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Incyte

984 – Ponatinib and Chemotherapy in Young Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Results of Ponalfil Clinical Trial after Completion of Recruitment Abstract Presentation Slides Abstract View author list and disclosures Author(s): Josep-Maria Ribera, Olga García, Pau Montesinos, MD, PhD, Pilar Martinez, MD, Jordi Esteve, MD, PhD, Daniel Esteban, María José Moreno,…

Read the full article

Abstract 398 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Incyte

398 – Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib Abstract Presentation Slides Abstract View author list and disclosures Author(s): Yuya Sasaki, MD, PhD, Hagop M. Kantarjian, MD, Nicholas J. Short, MD, Nitin Jain, MD, Koji Sasaki, MD, Farhad Ravandi, MBBS,…

Read the full article

Abstract 1026 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Incyte

1026 – Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome–Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): Phallcon Study Abstract Presentation Slides Abstract View author list and disclosures Author(s): Elias Jabbour, MD, Giovanni Martinelli, MD, Marco Vignetti, MD, Hagop M. Kantarjian, MD, David Gomez-Almaguer, MD, Yosuke Minami, MD, PhD, Hervé Dombret, MD,…

Read the full article